This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
T-knife Launches Phase 1 Trial of CRISPR T Cell Therapy
The first-in-human ATLAS trial will test PRAME-targeting CRISPR T cells in advanced cancers
03/16/2026
2 min read
News
